This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kalvista Pharmaceuticals Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Robert Neil Ward
Introduction
Robert Neil Ward is a notable inventor based in Flintshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral solid dosage forms. His work focuses on innovative solutions that enhance the efficacy of treatments.
Latest Patents
Robert Neil Ward holds 1 patent for his invention titled "Dosage forms comprising a plasma kallikrein inhibitor." This patent relates to oral solid dosage forms that include a plasma kallikrein inhibitor, specifically a solid form (Form 1) of the compound of Formula A. The invention also outlines methods for preparing these oral solid dosage forms using Form 1 of the compound.
Career Highlights
Ward is associated with Kalvista Pharmaceuticals Limited, where he applies his expertise in pharmaceutical innovations. His work at Kalvista has been instrumental in advancing the development of new therapeutic options.
Collaborations
Throughout his career, Robert has collaborated with notable colleagues, including John Herman Collett and Gary Paul Cook. These partnerships have contributed to the successful development of innovative pharmaceutical solutions.
Conclusion
Robert Neil Ward's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to advancing medical treatments. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile